120 related articles for article (PubMed ID: 8210494)
1. SR 48968, a neurokinin A (NK2) receptor antagonist.
Emonds-Alt X; Advenier C; Croci T; Manara L; Neliat G; Poncelet M; Proietto V; Santucci V; Soubrié P; Van Broeck D
Regul Pept; 1993 Jul; 46(1-2):31-6. PubMed ID: 8210494
[No Abstract] [Full Text] [Related]
2. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.
Gether U; Yokota Y; Emonds-Alt X; Brelière JC; Lowe JA; Snider RM; Nakanishi S; Schwartz TW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6194-8. PubMed ID: 7687062
[TBL] [Abstract][Full Text] [Related]
3. Identification of both NK1 and NK2 receptors in guinea-pig airways.
McKee KT; Millar L; Rodger IW; Metters KM
Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
[TBL] [Abstract][Full Text] [Related]
4. The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors.
Chung FZ; Wu LH; Vartanian MA; Watling KJ; Guard S; Woodruff GN; Oxender DL
Biochem Biophys Res Commun; 1994 Feb; 198(3):967-72. PubMed ID: 8117304
[TBL] [Abstract][Full Text] [Related]
5. SR 48968 specifically depresses neurokinin A- vs. substance P-induced hyperalgesia in a nociceptive withdrawal reflex.
Yashpal K; Hui-Chan CW; Henry JL
Eur J Pharmacol; 1996 Jul; 308(1):41-8. PubMed ID: 8836630
[TBL] [Abstract][Full Text] [Related]
6. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor.
Emonds-Alt X; Vilain P; Goulaouic P; Proietto V; Van Broeck D; Advenier C; Naline E; Neliat G; Le Fur G; Brelière JC
Life Sci; 1992; 50(15):PL101-6. PubMed ID: 1313515
[TBL] [Abstract][Full Text] [Related]
7. Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle.
Sellers DJ; Chapple CR; W Hay DP; Chess-Williams R
Eur Urol; 2006 Mar; 49(3):510-8. PubMed ID: 16420969
[TBL] [Abstract][Full Text] [Related]
8. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
9. Human tachykinin NK2 receptor: a comparative study of the colon and urinary bladder.
Warner FJ; Miller RC; Burcher E
Clin Exp Pharmacol Physiol; 2003 Sep; 30(9):632-9. PubMed ID: 12940880
[TBL] [Abstract][Full Text] [Related]
10. Spiro-substituted piperidines as neurokinin receptor antagonists. I. Design and synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro [isobenzofuran-1(3H),4'piperidin]-1'-yl)butyl]-N-methylbenzamide, YM-35375, as a new lead compound for novel neurokinin receptor antagonists.
Kubota H; Fujii M; Ikeda K; Takeuchi M; Shibanuma T; Isomura Y
Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):351-4. PubMed ID: 9501470
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro activity of SR 48,968, a non-peptide tachykinin NK-2 receptor antagonist.
Giuliani S; Patacchini R; Giachetti A; Maggi CA
Regul Pept; 1993 Jul; 46(1-2):314-6. PubMed ID: 7692525
[No Abstract] [Full Text] [Related]
12. Molecular determinants of peptide and nonpeptide NK-2 receptor antagonists binding sites of the human tachykinin NK-2 receptor by site-directed mutagenesis.
Giolitti A; Cucchi P; Renzetti AR; Rotondaro L; Zappitelli S; Maggi CA
Neuropharmacology; 2000 Jun; 39(8):1422-9. PubMed ID: 10818258
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues involved in ligand binding to the neurokinin-2 receptor.
Huang RR; Vicario PP; Strader CD; Fong TM
Biochemistry; 1995 Aug; 34(31):10048-55. PubMed ID: 7543277
[TBL] [Abstract][Full Text] [Related]
14. Receptor characterization of the spinal action of neurokinins on nociception: a three receptor hypothesis.
Couture R; Boucher S; Picard P; Regoli D
Regul Pept; 1993 Jul; 46(1-2):426-9. PubMed ID: 7692557
[No Abstract] [Full Text] [Related]
15. Pharmacologic evaluation of neurokinin-2 receptor antagonists in the guinea pig respiratory tract.
Venugopal CS; Christopher CL; Wilson SM; Polikepahad S; Dequeant E; Holmes EP
Am J Vet Res; 2004 Jul; 65(7):984-91. PubMed ID: 15281659
[TBL] [Abstract][Full Text] [Related]
16. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors.
Advenier C; Naline E; Toty L; Bakdach H; Emonds-Alt X; Vilain P; Brelière JC; Le Fur G
Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1177-81. PubMed ID: 1332556
[TBL] [Abstract][Full Text] [Related]
17. 4-Alkylpiperidines related to SR-48968: potent antagonists of the neurokinin-2 (NK2) receptor.
Jacobs RT; Shenvi AB; Mauger RC; Ulatowski TG; Aharony D; Buckner CK
Bioorg Med Chem Lett; 1998 Jul; 8(14):1935-40. PubMed ID: 9873462
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of capsazepine and the NK2 antagonist SR 48968 on bronchoconstriction evoked by sensory nerve stimulation in guinea-pigs.
Satoh H; Lou YP; Lee LY; Lundberg JM
Acta Physiol Scand; 1992 Dec; 146(4):535-6. PubMed ID: 1337239
[No Abstract] [Full Text] [Related]
20. Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo.
Giuliani S; Tramontana M; Lecci A; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):327-35. PubMed ID: 8878063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
